The Uttam Hindu
Home > #Biopharma
Budget 2026 boosts biopharma with ₹10,000 crore Shakti scheme

Budget 2026 boosts biopharma with ₹10,000 crore Shakti scheme

by Kajal Luthra |2026-02-01 06:09:30
SK bioscience wins patent case against Moderna in South Korea

SK bioscience wins patent case against Moderna in South Korea

by The Uttam Hindu |2025-04-23 09:47:36
US court clears way for Sun Pharma to launch autoimmune disorder drug

US court clears way for Sun Pharma to launch autoimmune disorder drug

by The Uttam Hindu |2025-04-10 11:11:19
Celltrion targets $3.46 bn in sales this year on biosimilars

Celltrion targets $3.46 bn in sales this year on biosimilars

by The Uttam Hindu |2025-03-18 10:22:45
Celltrion launches autoimmune disease treatment in US

Celltrion launches autoimmune disease treatment in US

by The Uttam Hindu |2025-03-13 09:32:28
S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar

S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar

by The Uttam Hindu |2025-03-10 08:26:48
Celltrions autoimmune disease treatment gets approval in Europe

Celltrion's autoimmune disease treatment gets approval in Europe

by The Uttam Hindu |2025-02-24 05:38:22
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment

Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment

by The Uttam Hindu |2025-01-31 09:17:54
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment

Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment

by The Uttam Hindu |2025-01-31 07:49:33
X